Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness)
- DOI
- 10.1007/s12282-026-01867-y
- Published
- 2026-05-23
- Container
- Breast Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12282-026-01867-y,
title = {Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness)},
author = {Tomoe Taji and Yukari Uemura and Yuri Kimura and Noriko Maeda and Aki Ito and Hirohito Seki and Daisuke Takabatake and Michiko Harao and Shogo Nakamoto and Ryoichi Matsunuma and Chinatsu Koganezawa and Takayuki Iwamoto and Hirofumi Mukai and Yuichiro Kikawa},
year = {2026},
journal = {Breast Cancer},
doi = {10.1007/s12282-026-01867-y},
url = {https://doi.org/10.1007/s12282-026-01867-y}
}RIS
TY - JOUR TI - Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness) AU - Tomoe Taji AU - Yukari Uemura AU - Yuri Kimura AU - Noriko Maeda AU - Aki Ito AU - Hirohito Seki AU - Daisuke Takabatake AU - Michiko Harao AU - Shogo Nakamoto AU - Ryoichi Matsunuma AU - Chinatsu Koganezawa AU - Takayuki Iwamoto AU - Hirofumi Mukai AU - Yuichiro Kikawa PY - 2026 JO - Breast Cancer DO - 10.1007/s12282-026-01867-y UR - https://doi.org/10.1007/s12282-026-01867-y ER -
APA
Taji, T., Uemura, Y., Kimura, Y., Maeda, N., Ito, A., Seki, H., Takabatake, D., Harao, M., Nakamoto, S., Matsunuma, R., Koganezawa, C., Iwamoto, T., Mukai, H., & Kikawa, Y. (2026). Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness). Breast Cancer. https://doi.org/10.1007/s12282-026-01867-y
Source records
- crossref · retrieved 2026-09-26T14:29:48.437Z